Showing results (41-50 of 50) with videos related to
Sort By:
Pageof 5
You have reached the last page of results.This site can display upto 50 results.
American Journal of Ophthalmology|July 28, 2026
Systemic treatment with the ROCK2 inhibitor belumosudil in ocular chronic graft versus host diseaseYibo Wu, Bei Ye, Xiaoyu Lai, et al.Biochemical Pharmacology|January 16, 2026
Mertk-driven tunneling nanotube formation in macrophages preserves mitochondrial homeostasis during kidney Ischemia-Reperfusion AttackJun Zeng, Ruoqing Li, Liyin Chai, et al.Transplantation and Cellular Therapy|August 3, 2025
NUP98 Rearrangement Dynamics Predict Outcomes in Adult Patients With Acute Myeloid Leukemia Undergoing Allogeneic Hematopoietic Stem Cell Transplantation: A Multicenter Real-World StudyXiaolin Yuan, Lihong Ni, Ting Chen, et al.Cell Transplantation|February 12, 2026
Prognostic impact of clinico-genetic characteristics and donor types in NPM1-mutated AML undergoing allogeneic hematopoietic stem cell transplantationXiaolin Yuan, Yibo Wu, Tingting Yang, et al.Cancer|June 18, 2025
KRAS mutation status critically determines the clinical outcome of patients with KMT2A-rearranged acute myeloid leukemiaYibo Wu, Xiaolin Yuan, Xiaoyu Lai, et al.Bone Marrow Transplantation|January 9, 2026
Validation of risk stratification and novel prognostic biomarkers in asian adult HSCT recipients with TA-TMA: A multicenter real-world studyYibo Wu, Xiaolin Yuan, Lieguang Chen, et al.Clinical & Translational Immunology|July 4, 2025
Cellular hierarchy for understanding heterogeneity of acute myeloid leukaemia with t(8;21)/RUNX1-RUNX1T1Yibo Wu, Xiaolin Yuan, Xiaoyu Lai, et al.Annals of Hematology|October 24, 2025
Developmental stage modulates the prognostic impact of RAS pathway mutations in AML patients undergoing Allo-HSCTXiaolin Yuan, Yibo Wu, Yanan Wang, et al.The New England Journal of Medicine|April 24, 2024
Sequential CD7 CAR T-Cell Therapy and Allogeneic HSCT without GVHD ProphylaxisYongxian Hu, Mingming Zhang, Tingting Yang, et al.Nature Cancer|June 10, 2026
Iron-mediated ferroptosis impairs CAR-T cell function and antitumor efficacyDelin Kong, Tingting Yang, Mengyu Zhao, et al.Pageof 5